Investors are turning to safe-haven amid coronavirus concerns, with gold jumping to its highest level in 7 years. Yahoo Finance’s Jared Blikre joins Seana Smith to discuss on The Ticker.
Investors are turning to safe-haven amid coronavirus concerns, with gold jumping to its highest level in 7 years. Yahoo Finance’s Jared Blikre joins Seana Smith to discuss on The Ticker.
(Bloomberg) -- The quietest week in stocks so far in 2021 has Wall Street wondering what will break the calm.Equity trading volume plunged as the S&P 500 marched to an all-time high, with the five-day average across U.S. exchanges dropping to 9.5 billion shares traded -- the lowest since October, according to Bloomberg data. Friday was particularly placid, with just 8.7 billion shares moving, the lowest daily total since Christmas Eve.The lull felt especially abrupt after 13 months of frenzied trading brought the fastest bear market ever and a furious rally not equaled in 90 years. Stuck-at-home traders turned online brokerages into casinos, while vaccine approvals in November sparked more euphoria, spurring investors into stocks they’d shunned for months. Since then, more than $575 billion has poured into the market, exceeding total inflows for the prior 12 years combined, according to Bank of America data.That all changed in April, and theories abound as to what’s behind it. The retail mania has cooled as economic restrictions eased. Stimulus bets got settled. A brief bout of selling sparked higher yields was becalmed by a chorus of Federal Reserve officials. Economic data is starting to help justify valuations. There are just fewer major issues left to drive massive market bets. No matter, say money managers, the tranquility won’t last.“We were going 100 miles an hour and now we’re back within the speed limit,” Arthur Hogan, chief market strategist at National Securities, said by phone. “We’re going to see a resurgence of volumes and volatility because this year is going to be like no other year that people have ever seen in terms of economic growth, earnings growth, inflation, a brand-new framework for the Federal Reserve.”After a 1.4% rally Monday, the S&P 500 ground out three more records to end the week as trading volumes slowed to pre-pandemic averages. The index notched a third straight weekly gain, and the Cboe Volatility Index slipped to its lowest level in 14 months. Fading bets on Fed hikes spurred the biggest weekly drop in 5-year Treasury yields since June.Traders whipsawed by the pandemic tumult are unmoved by the calm and point to signs that more turbulence is to come. Take the VIX. At 17, it’s stubbornly elevated compared to its average of 14.9 in the seven years through 2019. Bets that the summer will bring more market chaos have pushed the spread between the VIX and implied 30-day volatility four months from now to the widest level in almost nine years.Bond markets show similar expectations for fireworks -- short interest in the $14 billion iShares 20+ Year Treasury Bond exchange-traded fund as a percentage of shares outstanding rose to the highest level since 2017 this week, IHS Markit Ltd. data show, even as the ETF rallied.Meanwhile, Wall Street prognosticators think the advance that pushed S&P 500 to dot-com-era valuations is likely exhausted for the year. At an all-time high of 4,128.80, the index closed Friday ahead of the average year-end target of 4,099 from strategists tracked by Bloomberg.Skeptics have cited everything from rising yields to stretched valuation and potential tax hikes as reason for caution. Tobias Levkovich, chief U.S. equity strategist at Citigroup Inc. whose 2021 target sat at 3,800, expects the Fed to start rolling back monetary stimulus later this year and earnings guidance to weaken, posing headwinds for stocks and stoking volatility.“Sentiment is in very worrisome territory as is valuation, yet money flows continue to push indices higher,” Levkovich wrote in a note earlier this week. “Huge fiscal stimulus and supportive central banks have created the notion of there being no need to be risk averse,” he added. “Indeed, all developments are perceived as positive news. Yet, such one-sided views are not usually a good starting point.”Kim Forrest of Bokeh Capital Partners is feeling more optimistic. She expects the kickoff of what’s expected to be the best earnings season since 2018 to breathe life back into the stocks, with big lenders including JPMorgan Chase & Co. and Citigroup Inc. set to report next week. First-quarter profits from S&P 500 firms probably expanded 24%, led by carmakers, banks and retailers, data compiled by Bloomberg Intelligence show.“Unless there’s some other craziness going, like Covid, earnings always drive the market,” said Forrest, the firm’s chief investment officer. “We are heading into earnings season and the bar has been set really low, and I think the first quarter has been pretty good, so that’s encouraging.”For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
Gold futures are trading sharply lower on Friday, pressured by rising Treasury yields and a stronger U.S. Dollar. The moves are likely being fueled by profit-taking ahead of the weekend, but some are saying that robust economic data from China boosted hopes of a swift recovery. A fast paced recovery will bring central banks closer to lifting their current easy monetary policy, which would pressure gold prices.
A rebound in growth and technology stocks has investors gauging whether a months-long rally in the shares of banks, energy companies and other economically sensitive names is running on empty or simply refueling. The Russell 1000 value index started 2021 with its biggest quarterly outperformance relative to its growth counterpart in 20 years, as investors poured money into the shares of battered companies they thought would benefit most from a vaccine-generated reopening of the U.S. economy. The script has flipped since mid-March, with the Russell growth index gaining over 6% compared to a rise of just over 2% for value.
(Bloomberg) -- Oil posted its worst week in three amid concerns that rising global coronavirus cases are slowing the economic recovery.West Texas Intermediate futures ended the week down 3.5%, the biggest weekly loss since mid-March. With the Organization of Petroleum Exporting Countries and its allies planning to start raising output, markets are now focused on whether the demand recovery will be enough to absorb growing supplies.While consumption is climbing in India and the U.S., rising virus cases and the possibility of stricter travel limits in Europe are muddying the forecast and putting pressure on crude. Oil plunged Monday after the U.K. said it may delay global travel beyond May 17.“The Covid situation has really not had a strong recovery in Europe and across many emerging markets, and that’s really weighed down the demand outlook for oil,” said Edward Moya, senior market analyst at Oanda Corp.A stronger dollar also weighed on oil Friday, reducing the appeal of commodities priced in the currency. A higher-than-expected rise in U.S. March producer prices stoked inflation concerns.“If we get some hotter inflation readings, that could send Treasury yields higher again,” negatively impacting oil, according to Moya.Saudi Arabia said it remains confident that OPEC+ made the right decision to increase production over the next three months, and there are signs of better days ahead for demand that could soak up the additional barrels.India’s oil-products demand in March rose to the strongest since late 2019, while Germany reiterated support for a short, strict lockdown in the country. In the U.S., traffic is roaring back in some cities, an indication of stronger demand this summer.Making the calculation even more complex are ongoing talks between Iran and world powers to resuscitate a 2015 nuclear deal, which would set the stage for the Persian Gulf to increase supply. Negotiations are set to continue next week, though no direct contacts between Iranian and U.S. envoys have yet been made.Crude in New York has around $60 a barrel since mid-March, with market volatility slumping to the lowest in a month. Prices haven’t broken out of a $5 trading range over recent weeks, and have oscillated in smaller and smaller bands with each passing day -- creating a technical pattern some see as indicative of a breakout higher.“We’re toward the lower end of the range on concerns over the global economic recovery,” said Gary Cunningham, director at Stamford, Connecticut-based Tradition Energy. “Until we start to see some jet fuel demand come back, Asian demand pick up and European countries ease restrictions,” prices may not surge much higher in the near term.(A previous version of the story corrected size and scope of India oil-products consumption in third paragraph.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
The publicly traded app developer has now spent $100 million on bitcoin and ether.
Gold markets pulled back a bit during the trading session on Friday, to test the short term break out.
The e-commerce company Alibaba Group is fined $2.75bn for violating anti-monopoly rules.
Krpytoin also filed for a bitcoin ETF on Friday.
(Bloomberg) -- A liquefied natural gas trading company that was until recently based in Dubai and part of India’s Hiranandani Group is being liquidated, according to a letter to creditors seen by Bloomberg News.HE Mideast Ltd. had insufficient funds to meet its debts, according to the letter, dated April 1, seen by Bloomberg. The firm defaulted on at least $50 million worth of debt to LNG suppliers including Malaysia’s Petroliam Nasional Bhd and Royal Dutch Shell Plc, said people with knowledge of the matter.The company took speculative positions on physical and paper LNG trades over the last few years, which strapped them with debt they were unable to repay, said the people, who requested anonymity as the matter is private.Novato Investing Ltd., current owner of HE Mideast, declined to comment on any liquidation. Shell declined to comment, and Petronas didn’t respond to a request to comment. Petronas signed a supply deal with the company in 2018. Shell and Petronas declined to comment.Novato has appointed FTI Consulting as liquidator for HE Mideast, and will hold its first meeting with creditors on April 20, according to the letter to creditors. FTI declined to comment.HE Mideast changed its name from H-Energy Mideast DMCC in July 2020, and was established as a Dubai-based trading firm by H-Energy Global Ltd. in 2014, according to a certificate of name change and trading license seen by Bloomberg News. The company recently had ownership transferred to Novato Investing Ltd. and was re-domiciled to the British Virgin Islands, the people said.H-Energy Global, a member of India’s Hiranandani Group, is a smaller, new entrant in the LNG space.(Updates with no comment from Shell and Petronas in the fourth paragraph)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
The president is being urged to roll more direct aid money into his infrastructure bill.
(Reuters) -The S&P 500 and the Dow rose on Friday to close at record highs, posting a third straight weekly rise partly on a lift from growth stocks, with a late-day rally building gains ahead of quarterly earnings season next week. A pullback in the 10-year U.S. Treasury yield from a 14-month high hit in late March encouraged buying in growth.
Elsewhere, gold futures fell 0.6% to $1,747.35/oz, while EUR/USD traded 0.2% lower at 1.1891.
The price action comes just ahead of a highly anticipated Nasdaq listing for leading U.S. crypto exchange Coinbase.
Melvin Capital is giving the Reddit crowd something to cheer about on a Friday, after the hedge fund rang up a 49% first-quarter loss, according to a report from Bloomberg News on Friday.
The S&P 500 and the Dow climbed to record highs on Friday, buoyed in part by gains in growth stocks, but gains were muted ahead of the start of quarterly earnings season next week. Growth names have found their footing over the past two weeks after being outperformed by value stocks for most of the year.
(Bloomberg) -- India’s online-education startup Byju’s is raising about $1 billion from new investors including B Capital Group, founded by former Facebook cofounder Eduardo Saverin, Baron Funds and XN, a person familiar with the matter said.The infusion that values India’s online-lessons platform at about $15 billion is among the largest recent capital increases in India. Existing backers, including private equity giant Silver Lake Management, Owl Ventures and T Rowe Price, are investing about $100 million each in the funding round, which is yet to close, said the person, who did not want to be identified because discussions are confidential.The startup remains in discussions to close the round with a further $200 to $300 million in the coming weeks at a slightly higher valuation, the person said.The large investment into Byju’s comes as fundraising by Indian startups reaches a feverish pitch. Half-a-dozen companies announced unicorn-level capital raises earlier this week. A spokeswoman for Byju’s declined to comment on the fundraising.Byju Raveendran, the education company’s founder and chief executive officer, said in an interview earlier in the week that the platform is looking to make acquisitions to quicken the pace of growth in markets like the U.S. The 39-year-old former teacher and son of educators said the pandemic has dramatically improved attitudes about online learning among teachers, students and parents.The startup’s K-12 learning app has more than 80 million registered users in India, who mainly learn simplified math and science concepts through animated games and videos.It is now branching into offline exam preparation as well as one-on-one lessons in coding and math in global markets including the U.S., Latin America and Australia. The online lessons startup’s early investors include Facebook founder Mark Zuckerberg’s Chan-Zuckerberg Initiative, Naspers Ltd. and Tiger Global Management.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
Five of the nation's largest banks are asking shareholders to reject racial equity resolution audit less than a year after the Black Lives Matter movement
For all the hard-charging talk about electric cars, you might think that they were taking over the U.S. market. Electric cars there are suddenly 14% of the market, or 23% if we count plug-in hybrids that burn fossil fuel for backup. In the U.S., meanwhile, a $7,500 credit for every electric vehicle phases out after companies sell 200,000 of them, so (TSLA) (ticker: TSLA) and (GM) (GM), the biggest EV players, no longer benefit.
After a volatile first quarter, Q2 has kicked off in style, and the major indexes sit at – or hover near – all-time highs. The government bond market has also been steadying as yields have pulled back after rising higher earlier in the year, soothing investor fears that inflation could get out of hand. Moreover, the economic recovery seems to be gathering steam at a faster pace than anticipated. “We had been expecting the data to improve about this time, and early signals are that the recovery is absolutely on track,” said Hugh Gimber, J.P. Morgan’s global market strategist. “This is the period where the forecast of a strong recovery in growth is starting to look more like the fact of a strong recovery in growth.” Against this backdrop, the analysts at J.P. Morgan have pinpointed 2 names which they believe are set for strong growth in the year ahead; both are expected to handsomely reward investors with at least 80% of gains over the coming months. We ran them through TipRanks database to see what other Wall Street's analysts have to say about them. Tencent Music Entertainment (TME) We’ll start in China, where Tencent Music Entertainment is the offspring of China’s giant online venture company, Tencent, and Spotify, the Swedish streaming company that makes music and playlists easy. Tencent Music has seen consistently strong sales and earnings for the past year, with the top line growing year-over-year in each quarter of 2020. The Q4 report showed $1.26 billion in the top line, the highest in the last two years, along with 12 cents per share in earnings, up 33% year-over-year. Strong streaming revenue, which showed 29% growth, helped drive the results. And, Tencent Music, through its variety of apps, is the top music streaming service in the Chinese online market – as shown by the 40.4% yoy increase in paid subscribers during Q4. In its quarterly results, the company reported 4.3 million net new users in Q4, to reach 56 million active premium accounts across its apps. That said, the stock has pulled back sharply recently, as like many other high-flying growth names, worries regarding an overheated valuation have come to the fore. But pullbacks often spell opportunity, and covering the stock for JPM, Alex Yao notes the strong subscription growth, as well as the potential in the company’s other businesses, online ads and long-form audio, for monetization. “We believe TME is entering a healthy development cycle with successive growth engines: 1) music subscription remains the core revenue driver with consistent paying ratio improvement, 2) ads revenue ramps up quickly, and 3) active investments in long-form audio initiative, which could become a new growth driver in 2022 and afterwards," Yao noted. To this end, Yao puts a $36 price target on TME, suggesting a one-year upside of 84%, to back his Overweight (i.e. Buy) rating on the stock. (To watch Yao’s track record, click here) Overall, TME has a thumbs up from Wall Street. Of the 11 reviews on record, 7 are to Buy, 3 are to Hold, and 1 says Sell, making the analyst consensus a Moderate Buy. The shares are priced at $19.50, and their $30.19 average price target implies an upside of 55% for the months ahead. (See TME stock analysis on TipRanks) Y-mAbs Therapeutics (YMAB) The next JPM pick we’re looking at is Y-mAbs, a late-stage clinical biopharma company with a focus on pediatric oncology. The company is working on the development and commercialization of new antibody-based cancer therapeutics. Y-mAbs has one medication – Danyelza – approved for use to treat neuroblastoma in children age 1 and over, and a ‘broad and advanced’ pipeline of drug candidates in various stages of the clinical process, as well as five additional products in pre-clinical research stages. Having an approved drug is a ‘holy grail’ for clinical biopharmaceutical companies, and in 4Q20 Y-mAbs saw considerable income from Danyelza. The company announced at the end of December that it had agreed to sell the Priority Review Voucher for the drug to United Therapeutics for $105 million. Y-mAbs will retain the rights to 60% of the net proceeds from the sale, under an agreement with Memorial Sloan Kettering. Also in December, the company announced a license agreement with SciClone. The partnership gives Y-mAbs and Danyelza an opening for treating pediatric patients in China. The agreement includes Mainland China, Taiwan, Hong Kong, and Macau, and is worth up to $120 million for Y-mAbs. The company has entered other agreements making Danyelza available in Eastern Europe and Russia. Danyelza is Y-mAbs flagship product, but the company also has omburtamab in advanced stages of the pipeline. This drug candidate saw a setback in October last year, when the FDA refused to file the company's Biologics License Application, proposed for the treatment of pediatric patients with CNS/leptomeningeal metastasis. Y-mAbs has been in steady communication with the FDA since then, with a new target date for the BLA at the end of 2Q21 or early in 3Q21. These two drugs – one approved and one not yet – form the basis of the JPM outlook on this stock. Analyst Tessa Romero writes, “Our thesis revolves around the de-risked nature of the pediatric oncology pipeline. Our recent KOL feedback is enthusiastic about use of lead asset Danyelza in patients with high-risk neuroblastoma (NB). For second lead asset omburtamab in NB metastatic to the central nervous system (CNS/LM from NB), while the ‘Refuse to File’ last year and subsequent regulatory delays were certainly disappointing, we still see a high probability of approval for the product in the 2Q/3Q22 timeframe…” Looking ahead, Romero sees an upbeat outlook for the company: “Coupling our anticipation of a healthy launch for Danyelza, with regulatory/clinical momentum expected in the near- to mid-term, we see shares poised to rebound and see an attractive buying opportunity at current levels.” The analyst puts a $52 price target on YMAB shares, implying an upside of 86% for the year ahead, and supporting an Overweight (i.e. Buy) rating. (To watch Romero’s track record, click here) Overall, the Wall Street reviews break down 3 to 1 in favor of Buys versus Holds on Y-mAbs, giving the stock a Strong Buy consensus rating. The shares have an average price target of $61.25, suggestive of a 121% upside potential this year. (See YMAB stock analysis on TipRanks) To find good ideas for stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights. Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.
(Bloomberg) -- The battle for control of Arm Ltd.’s China business is escalating with new lawsuits aimed at keeping the unit’s controversial chief executive in power, further complicating SoftBank Group Corp.’s efforts to sell the business to Nvidia Corp.The dispute erupted almost a year ago in June after the board voted to oust Arm China Chief Executive Officer Allen Wu for conflicts of interest, but he refused to leave. Now the Chinese unit, which remains under Wu’s control, has filed lawsuits against three senior executives the board designated to replace him, according to people familiar with the matter. The previously unreported suits could take years to resolve, suggesting Wu may remain entrenched.Wu fired the three men -- including co-CEO Phil Tang -- but they were subsequently reinstated by the board. In the new lawsuits, Arm China is suing the trio, demanding they return company property, according to the people.Arm China declined to comment on any ongoing legal cases or possible settlement talks. It did say the three executives had caused “material damages” to the company and they had been terminated for legitimate reasons.Tang didn’t return requests for comment. Arm Ltd. declined to elaborate, saying it won’t comment on pending legal matters.The complex tussle has thrown into question the future of Arm, whose semiconductor technology is the world’s most widely used for smartphones and is increasingly deployed in computers. SoftBank founder Masayoshi Son agreed to sell the British chip designer to Nvidia for $40 billion last year, but the path for completing that transaction is growing increasingly difficult.The China dispute also raises questions about Beijing’s willingness to protect foreign investment in the world’s second-largest economy. Arm Ltd. sold a majority stake in the China unit to a consortium of investors, including Beijing-backed institutions. That has complicated the British firm’s efforts to manage Arm China and Wu, who has support from local authorities in Shenzhen.Both sides appear to be at a stalemate. Wu, a Chinese-born U.S. citizen, pulled back from signing settlement agreements worth tens of millions of dollars if he would leave the company, the people said, asking not to be identified talking about legal matters. At the same time, two minority shareholders in Arm China linked to Wu have filed lawsuits to overturn his June 4 dismissal, they said.SoftBank opened negotiations with him last year and had hoped to reach some sort of resolution, they said. Instead the court battles are deepening and the Japanese company has soured over the increasingly complicated dispute, the people said. SoftBank is now resigned to letting the legal proceedings take their course and there are no current negotiations with Wu, according to one of the people.“We are going through a leadership change in China; it’s taking time to resolve,” said Arm Ltd.’s Chief Executive Officer Simon Segars in an interview with Bloomberg Television recently. “It’s hard. But we are confident that’s going to get resolved.”SoftBank and Nvidia declined to comment on the dispute in China.Arm China said in a statement that Wu’s position “is compliant with legal registration and confirmed by China law and regulations.”Read more: Arm Takes Aim at Intel Chips in Biggest Tech Overhaul in DecadeThe standoff accords a relatively unknown executive outsized influence over one of the industry’s most important pieces of technology, in the world’s biggest internet and semiconductor market. Chinese companies need unfettered access to Arm’s products to push forward with the country’s attempts to make itself more independent in chip technology, an area where it’s largely reliant on imports. Beyond resolving the stalemate, Nvidia and SoftBank also need Beijing’s signoff to seal their deal, and it’s unclear whether Wu’s presence would complicate that.Wu’s hold on Arm China is partially due to local laws which make it difficult to change control of a company unless you’re physically in control of the company stamp and registration documents. He’s refused to give them up and has used company funds to pay for legal fees incurred in his attempt to fight off his dismissal, the people said.Arm China said payment of legal fees “is made in compliance with company policies as well as China laws and regulations.”His ultimate goals appear to be a large cash payoff and immunity from subsequent legal action, according to people who’ve spoken with him. Inside Arm China, which is responsible for selling licenses to its chip designs and fundamental technology in the country, Wu has told local staff he’s not going anywhere. He recently gave employees Chinese New Year cash presents in a red envelope with his surname on it.Arm China said the money came from Wu personally to show his appreciation to colleagues, a tradition at Chinese New Year in the country.Hearings in the case against the three executives are expected to take place in late May, one of the people said. Separately, two minority shareholders in Arm China have sued the Chinese entity in Shenzhen to nullify the board’s decision to oust Wu. These two cases are now being merged and hearings are slated for late April, the people said.Son told investors as recently as February that he expects to close the Arm sale and “I don’t have any Plan B.”Arm, for its part is trying to make sure that its technology remains pervasive in China despite U.S. sanctions intended to curb the supply of American technology to major companies like Huawei Technologies Co. While Arm is a U.K.-based company part of its operations are in the U.S. making its products subject to controls.The Chinese government has not stated its position on the Arm China leadership struggle, but the unit has several government-backed shareholders including sovereign wealth fund China Investment Corp. and the Silk Road Fund.In his interview with Bloomberg Television, Arm Ltd. CEO Segars said that the ten-month standoff hasn’t hurt Arm’s business in China. Lack of travel for face-to-face meetings during the pandemic has prolonged the process of changing leadership in China, he said.“When we announced the deal in September, we said it would take about 18 months,” he said. “We remain confident in that timeline.”For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.